CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Börse:
20,700€
6,15%
Echtzeit-Aktienkurs Corcept Therapeutics Inc.
Bid:
20,600€
Ask:
20,800€
Nachrichten zur Corcept Therapeutics Inc. Aktie
CORCEPT THERAPEUTICS INC: 10-K Report
10-K...…
Corcept Therapeutics EPS beats by $0.06, misses on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Insiderhandel: Vorstand verkauft Aktien von Corcept Therapeutics im Wert von 101.249 $
Maduck, Sean - Vorstand - Tag der Transaktion: 2021-02-11...…
Insiderhandel: Vorstand verkauft Aktien von Corcept Therapeutics im Wert von 253.903 $
Maduck, Sean - Vorstand - Tag der Transaktion: 2021-02-16...…
Why Corcept Therapeutics, Acasti Pharma And More Are Moving Today
Corcept Therapeutics (NASDAQ: CORT) shares were trading lower Tuesday after the company reported preliminary fourth-quarter sales results and issued fiscal…
Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2020....…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics Q4 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Accounting Officer verkauft Aktien von Corcept Therapeutics im Wert von 729.570 $
Lyon, Joseph Douglas - Vorstand - Tag der Transaktion: 2021-02-03...…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Corcept Therapeutics Incorporated im Wert von 143.687 $
Swisher, Daniel N Jr - Aufsichtsrat - Tag der Transaktion: 2021-01-19...…
Biggest Price Target Changes For Friday
HC Wainwright & Co. boosted the price target on Corcept Therapeutics Incorporated (NASDAQ: CORT) from $22 to $32. Corcept…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics Appoints Gillian M. Cannon, PhD, to Board of Directors
MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
NEW YORK , Nov. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APVO,…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics (CORT) Lags Q3 Earnings and Revenue Estimates
Corcept (CORT) delivered earnings and revenue surprises of -19.05% and -4.23%, respectively, for the quarter ended September 2020. Do the…
Corcept Therapeutics -5% after Q3 miss and lower guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CORCEPT THERAPEUTICS INC: 10-Q Report
10-Q...…
Corcept Therapeutics: Q3 Earnings Insights
Shares of Corcept Therapeutics (NASDAQ:CORT) fell 4.49% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share fell…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics EPS beats by $0.01, misses on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics Q3 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Director verkauft Aktien von Corcept Therapeutics im Wert von 88.301 $
Swisher, Daniel N Jr - Director - Tag der Transaktion: 2020-10-19...…
Why Corcept Therapeutics Soared 37% Higher in September
A patent decision on its cortisol therapy Korlym is expected to be rendered next month....…
Corcept Therapeutics Initiates Second Phase 2 Trial of Miricorilant to Treat Weight Gain Caused by Antipsychotic Medication
MENLO PARK, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Is the Options Market Predicting a Spike in Corcept Therapeutics (CORT) Stock?
Investors need to pay close attention to Corcept Therapeutics (CORT) stock based on the movements in the options market lately....…
Corcept Therapeutics Incorporated (CORT) Q2 2020 Earnings Call Transcript
CORT earnings call for the period ending July 31, 2020....…
CORCEPT THERAPEUTICS INC: 10-Q Report
10-Q...…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
MENLO PARK, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will…
Corcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian Cancer
MENLO PARK, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
CORCEPT THERAPEUTICS INC: 8-K Report
8-K...…
Corcept Therapeutics: A Long-Term Hold Despite Short-Term Sales Threat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…
Should You Climb on Board the Corcept Therapeutics Train-
This biotech company has seen huge growth over the past five years....…
Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2020....…
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q1 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates
Corcept (CORT) delivered earnings and revenue surprises of 19.05% and 7.35%, respectively, for the quarter ended March 2020. Do the…
Corcept Therapeutics EPS beats by $0.13, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
MENLO PARK, Calif. , May 04, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company…
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will…
Are You Looking for a Top Momentum Pick- Why Corcept Therapeutics (CORT) is a Great Choice
Does Corcept Therapeutics (CORT) have what it takes to be a top stock pick for momentum investors? Lets find out....…
Corcept Therapeutics Shares March Higher, Can It Continue-
As of late, it has definitely been a great time to be an investor in Corcept Therapeutics....…
Why You Shouldnt Bet Against Corcept Therapeutics (CORT) Stock
Corcept Therapeutics (CORT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry…
CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETY
MENLO PARK, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…